Unknown

Dataset Information

0

Hepatocyte-Specific Expression of Human Carboxylesterase 1 Attenuates Diet-Induced Steatohepatitis and Hyperlipidemia in Mice.

ABSTRACT: Rodents have at least five carboxylesterase 1 (Ces1) genes, whereas there is only one CES1 gene in humans, raising the question as to whether human CES1 and mouse Ces1 genes share the same functions. In this study, we investigate the role of human CES1 in the development of steatohepatitis or dyslipidemia in C57BL/6 mice. Hepatocyte-specific expression of human CES1 prevented Western diet or alcohol-induced steatohepatitis and hyperlipidemia. Mechanistically, human CES1 induced lipolysis and fatty acid oxidation, leading to a reduction in hepatic triglyceride and free fatty acid levels. Human CES1 also reduced hepatic-free cholesterol levels and induced low-density lipoprotein receptor. In addition, human CES1 induced hepatic lipoprotein lipase and apolipoprotein C-II expression. Conclusion: Hepatocyte-specific overexpression of human CES1 attenuates diet-induced steatohepatitis and hyperlipidemia.

SUBMITTER: Xu Y 

PROVIDER: S-EPMC7109343 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Hepatocyte-Specific Expression of Human Carboxylesterase 1 Attenuates Diet-Induced Steatohepatitis and Hyperlipidemia in Mice.

Xu Yanyong Y   Zhu Yingdong Y   Bawa Fathima Cassim FC   Hu Shuwei S   Pan Xiaoli X   Yin Liya L   Zhang Yanqiao Y  

Hepatology communications 20200220 4

Rodents have at least five carboxylesterase 1 (<i>Ces1</i>) genes, whereas there is only one <i>CES1</i> gene in humans, raising the question as to whether human <i>CES1</i> and mouse <i>Ces1</i> genes share the same functions. In this study, we investigate the role of human CES1 in the development of steatohepatitis or dyslipidemia in C57BL/6 mice. Hepatocyte-specific expression of human CES1 prevented Western diet or alcohol-induced steatohepatitis and hyperlipidemia. Mechanistically, human CE  ...[more]

Similar Datasets

Unknown Xanthine oxidase inhibition attenuates insulin resistance and diet-induced steatohepatitis in mice.
| S-EPMC6972756 | biostudies-literature
Unknown Loss of GPR40 in LDL receptor-deficient mice exacerbates high-fat diet-induced hyperlipidemia and nonalcoholic steatohepatitis.
| S-EPMC9635748 | biostudies-literature
Unknown Hepatocyte-specific deletion of Janus kinase 2 (JAK2) protects against diet-induced steatohepatitis and glucose intolerance.
| S-EPMC3323042 | biostudies-literature
Unknown VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice.
| S-EPMC3756672 | biostudies-literature
Unknown Intestine-Specific Overexpression of Carboxylesterase 2c Protects Mice From Diet-Induced Liver Steatosis and Obesity.
| S-EPMC6357831 | biostudies-literature
Unknown Loss of Hepatocyte-Specific PPAR<i>γ</i> Expression Ameliorates Early Events of Steatohepatitis in Mice Fed the Methionine and Choline-Deficient Diet.
| S-EPMC7211257 | biostudies-literature
Unknown Atorvastatin Attenuates Diet-Induced Non-Alcoholic Steatohepatitis in APOE*3-Leiden Mice by Reducing Hepatic Inflammation.
| S-EPMC10178767 | biostudies-literature
Unknown β-Cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing inflammatory gene expression in mice.
| S-EPMC4032271 | biostudies-literature
Unknown MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice.
| S-EPMC3753180 | biostudies-literature
Unknown Probiotics suppress nonalcoholic steatohepatitis and carcinogenesis progression in hepatocyte-specific PTEN knockout mice.
| S-EPMC9519992 | biostudies-literature